{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:22:19Z","timestamp":1793913739689,"version":"4.8.0"},"reference-count":37,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Africa faces again a new outbreak of mpox, heavily burdening the Democratic Republic of Congo (DRC). Factors such as biological and ecological changes in the virus, waning of immunity to smallpox, socio-economic challenges, and global economic strain are fueling this epidemic. To analyse the drivers of the mpox outbreak in DRC, review the international and local response, and draw lessons from the COVID-19 pandemic to propose strategies for building epidemic-resilient healthcare systems in the region. The focus is on the DRC, where the mpox epidemic is concentrated, and the broader African region, assessing both rural and urban healthcare contexts. This study synthesises epidemiological data, global health policies, and local health system responses. Key insights are drawn from COVID-19 case studies, and assessment of access to diagnostics and vaccines. The DRC hosts over 95% of Africa\u2019s mpox cases, with significant challenges in human-wildlife interactions, poverty, and weakened healthcare systems exacerbated by COVID-19. Vaccine shortages, diagnostic delays, and uneven international support reflect a repeat of challenges seen during COVID-19. Localised vaccine and diagnostics production, improved risk communication, and digital health tools are highlighted as critical interventions. An epidemic-resilient healthcare framework, leveraging local production of medical products, regulatory empowerment, and real-time data collection, is essential for controlling mpox and future outbreaks. This study underscores the need for African-led solutions, addressing socio-economic drivers, enhancing local capacities, and fostering international solidarity to mitigate future epidemic threats.<\/jats:p>","DOI":"10.4102\/jphia.v16i1.874","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T07:24:25Z","timestamp":1743492265000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Mpox after COVID-19 in Africa: Different epidemic, similar challenges"],"prefix":"10.4102","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8555-8596","authenticated-orcid":false,"given":"Gloria P.","family":"G\u00f3mez-P\u00e9rez","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/037n2rm85","id-type":"ROR","asserted-by":"publisher"}],"name":"Amsterdam Institute for Global Health and Development"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-7366","authenticated-orcid":false,"given":"Shem O.O.","family":"Sam","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02mgerj62","id-type":"ROR","asserted-by":"publisher"}],"name":"Great Lakes University of Kisumu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5131-3136","authenticated-orcid":false,"given":"Nicaise","family":"Ndembi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01d9dbd65","id-type":"ROR","asserted-by":"publisher"}],"name":"Africa Centres for Disease Control and Prevention"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5876-2564","authenticated-orcid":false,"given":"Tobias F. Rinke","family":"de Wit","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/037n2rm85","id-type":"ROR","asserted-by":"publisher"}],"name":"Amsterdam Institute for Global Health and Development"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"ref0","unstructured":"WHO. Smallpox and mpox (orthopoxviruses): WHO position paper, August 2024 [homepage on the Internet]. 2024 [cited 2024 Sept 25]. Available from: chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/iris.who.int\/bitstream\/handle\/10665\/378522\/WER9934-eng-fre.pdf?sequence=1"},{"key":"ref1","unstructured":"Africa CDC. Mpox Technical Factsheet [homepage on the Internet]. 2024 [cited 2024 Sept 2024]. Available from: https:\/\/africacdc.org\/download\/mpox-technical-factsheet\/"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Nachega JB, Mohr EL, Dashraath P, et al. Mpox in pregnancy \u2013 Risks, vertical transmission, prevention, and treatment. N Engl J Med. 2024;391:1267\u20131270. https:\/\/doi.org\/10.1056\/NEJMp2410045","DOI":"10.1056\/NEJMp2410045"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Djuicy DD, Sadeuh-Mba SA, Bilounga CN, et al. Concurrent Clade I and Clade II monkeypox virus circulation, Cameroon, 1979\u20132022. Emerg Infect Dis. 2024;30(3):432\u2013443. https:\/\/doi.org\/10.3201\/eid3003.230861","DOI":"10.3201\/eid3003.230861"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: Infection biology, epidemiology, and evolution. Viruses. 2020;12(11):1257. https:\/\/doi.org\/10.3390\/v12111257","DOI":"10.3390\/v12111257"},{"key":"ref5","unstructured":"Kinganda-Lusamaki E, Amuri-Aziza A, Fernandez N, et al. Clade I Mpox virus genomic diversity in the Democratic Republic of the Congo, 2018 \u2013 2024: Predominance of Zoonotic Transmission. medRxiv. 2024:2024.08.13.24311951."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Berry MT, Khan SR, Schlub TE, et al. Predicting vaccine effectiveness for mpox. Nat Commun. 2024;15(1):3856. https:\/\/doi.org\/10.1038\/s41467-024-48180-w","DOI":"10.1038\/s41467-024-48180-w"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Rimoin AW, Mulembakani PM, Johnston SC, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc. Natl. Acad. Sci. U.S.A. 2010;107(37):16262\u201316267. https:\/\/doi.org\/10.1073\/pnas.1005769107","DOI":"10.1073\/pnas.1005769107"},{"key":"ref8","unstructured":"Katoto PdM. Ongoing mpox outbreak in the Democratic Republic of Congo. Conference on Tropical Medicine and Global Health. 2024 Sep 19\u201321; D\u00fcsseldorf, Germany; 2024."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Wawina-Bokalanga T, Akil-Bandali P, Kinganda-Lusamaki E, et al. Co-circulation of monkeypox virus subclades Ia and Ib in Kinshasa Province, Democratic Republic of the Congo, July to August 2024. Euro Surveill. 2024;29(38):pii=2400592.","DOI":"10.2807\/1560-7917.ES.2024.29.38.2400592"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Ndodo N, Ashcroft J, Lewandowski K, et al. Distinct monkeypox virus lineages co-circulating in humans before 2022. Nat Med. 2023;29(9):2317\u20132324. https:\/\/doi.org\/10.1038\/s41591-023-02456-8","DOI":"10.1038\/s41591-023-02456-8"},{"key":"ref11","unstructured":"Global Finance. Economic Data \u2013 Poorest Countries in the World 2024 [homepage on the Internet]. 2024 [cited 2024 Sept 25]. Available from: https:\/\/gfmag.com\/data\/economic-data\/poorest-country-in-the-world\/"},{"key":"ref12","unstructured":"World Bank. The World Bank in DRC [homepage on the Internet]. 2024 [cited 2024 Sept 25]. Available from: https:\/\/www.worldbank.org\/en\/country\/drc\/overview#:~:text=DRC%20is%20among%20the%20five,in%20SSA%20lives%20in%20DRC"},{"key":"ref13","unstructured":"M\u00e9decins Sans Fronti\u00e8res. Conflict in DR Congo: What\u2019s happening & how to help [homepage on the Internet]. 2024. 2024 [cited 2024 Sept 25]. Available from: https:\/\/reliefweb.int\/report\/democratic-republic-congo\/conflict-dr-congo-whats-happening-how-help#:~:text=People%20in%20DRC%20have%20faced,making%20health%20care%20more%20difficult"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Phiri TN, Mutasa K, Rukobo S, et al. Severe acute malnutrition promotes bacterial binding over proinflammatory cytokine secretion by circulating innate immune cells. Sci Adv. 2023;9(44):eadh2284. https:\/\/doi.org\/10.1126\/sciadv.adh2284","DOI":"10.1126\/sciadv.adh2284"},{"key":"ref15","unstructured":"World Bank. Improved forest and landscape management in the democratic Republic of the Congo (DRC) [homepage on the Internet]. 2024 [cited 2024 Sept 25]. Available from: https:\/\/www.worldbank.org\/en\/news\/feature\/2024\/07\/31\/improved-forest-and-landscape-management-afe-democratic-republic-of-the-congo-drc"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Brashares JS, Golden CD, Weinbaum KZ, Barrett CB, Okello GV. Economic and geographic drivers of wildlife consumption in rural Africa. Proc. Natl. Acad. Sci. U.S.A. 2011;108(34):13931\u201313936. https:\/\/doi.org\/10.1073\/pnas.1011526108","DOI":"10.1073\/pnas.1011526108"},{"key":"ref17","unstructured":"Ndembi N, Ngongo N, Habtemariam MK, Kaseya J. Establishing self-sustaining vaccine manufacturing ecosystems: Africa\u2019s priority diseases [homepage on the Internet]. 2023. Available from: https:\/\/drive.google.com\/file\/d\/1YPRD1fAI5TpyTl0FAJmy1m7FXUEFFV1i\/view?usp=drive_link"},{"key":"ref18","unstructured":"Gavi. Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa [homepage on the Internet]. 2024 [cited 2024 Sept 25]. Available from: https:\/\/www.gavi.org\/news\/media-room\/gavi-signs-agreement-bavarian-nordic-rapidly-secure-500000-doses-mpox-vaccines"},{"key":"ref19","unstructured":"Africa CDC. Partnership for African vaccine manufacturing (PAVM) from aspiration to action [homepage on the Internet]. 2021 [cited 2024 Sept 25]. Available from: https:\/\/africacdc.org\/es\/event\/partnership-for-african-vaccine-manufacturing-pavm-from-aspiration-to-action\/?utm_source=rss&utm_medium=rss&utm_campaign=partnership-for-african-vaccine-manufacturing-pavm-from-aspiration-to-action"},{"key":"ref20","unstructured":"Gavi. Back to Regional manufacturing strategy African Vaccine Manufacturing Accelerator (AVMA) [homepage on the Internet]. 2024 [cited 2024 Sept 25]. Available from: https:\/\/www.gavi.org\/programmes-impact\/types-support\/regional-manufacturing-strategy\/avma"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Ndembi N, Fol\u00e1yan MnO. Now more than ever: Mpox renews the call for local pharmaceutical production for Africa\u2019s health security. J Public Health Afr. 2024;15(1):a783. https:\/\/doi.org\/10.4102\/jphia.v15i1.783","DOI":"10.4102\/JPHIA.v15i1.783"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Ndembi N, Aluso A, Habtemariam MK, et al. African leadership is critical in responding to public health threats. Nat Commun. 2024;15(1):877. https:\/\/doi.org\/10.1038\/s41467-024-45220-3","DOI":"10.1038\/s41467-024-45220-3"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Saied AA. Building Africa\u2019s first mRNA vaccine facility. Lancet. 2023;402(10398):287\u2013288. https:\/\/doi.org\/10.1016\/S0140-6736(23)01119-4","DOI":"10.1016\/S0140-6736(23)01119-4"},{"key":"ref24","unstructured":"Mo Ibrahim Foundation. Global Africa \u2013 Africa in the World and the World in Africa [homepage on the Internet]. 2023 [cited 2024 Sept 25]. Available from: chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/mo.ibrahim.foundation\/sites\/default\/files\/2023-04\/2023-facts-figures-global-africa.pdf"},{"key":"ref25","unstructured":"FIND. DxConnect Test Directory [homepage on the Internet]. 2024 [cited 2024 Sept 25]. Available from: https:\/\/finddx.shinyapps.io\/testdirexplorer_beta\/?_inputs_&sidebar=true&menubar=%22Explorer%22&button_outbreak=1"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Dzau V, Swaminathan S, Baker C, et al. The 100 Days Mission: How a new medical-countermeasures network can deliver equity and innovation. Lancet. 2023;402(10412):1507\u20131510. https:\/\/doi.org\/10.1016\/S0140-6736(23)01775-0","DOI":"10.1016\/S0140-6736(23)01775-0"},{"key":"ref27","unstructured":"Africa CDC. Mpox molecular diagnostic tests (RT-PCR). Recommendations as per 23 September 2024 [homepage on the Internet]. 2024 [cited 2024 Sept 27]. Available from: https:\/\/drive.google.com\/file\/d\/18cSYPbceIFYOGZ2hK59bHgxG-BC__fF0\/view?usp=drive_link"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Wollburg P, Markhof Y, Kanyanda S, Zezza A. Assessing COVID-19 vaccine hesitancy and barriers to uptake in sub-Saharan Africa. Commun Med (Lond). 2023;3(1):121. https:\/\/doi.org\/10.1038\/s43856-023-00330-9","DOI":"10.1038\/s43856-023-00330-9"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Kainja J, Makhumula C, Twabi HS, Gunde AM, Ndasauka Y. Cultural determinants of COVID-19 vaccines misinformation in Malawi. Hum Soc Sci Commun. 2024;11(1):1193. https:\/\/doi.org\/10.1057\/s41599-024-03743-6","DOI":"10.1057\/s41599-024-03743-6"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Boum Y, 2nd, Ndembi N. Mpox needs a locally tailored global response. BMJ. 2024;386:q2094. https:\/\/doi.org\/10.1136\/bmj.q2094","DOI":"10.1136\/bmj.q2094"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Wolday D, Gebrecherkos T, Arefaine ZG, et al. Effect of co-infection with intestinal parasites on COVID-19 severity: A prospective observational cohort study. EClinicalMedicine. 2021;39:101054. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101054","DOI":"10.1016\/j.eclinm.2021.101054"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Jongkees MJ, Tan NH, Geers D, et al. Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands. AIDS. 2024;38(9):1355\u20131365. https:\/\/doi.org\/10.1097\/QAD.0000000000003933","DOI":"10.1097\/QAD.0000000000003933"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Cevik M, Tomori O, Mbala P, et al. The 2023 \u2013 2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: Alarm bell for Africa and the World. Int J Infect Dis. 2024;146:107159. https:\/\/doi.org\/10.1016\/j.ijid.2024.107159","DOI":"10.1016\/j.ijid.2024.107159"},{"key":"ref34","unstructured":"Lake Region Economic Block. COVID-Dx Project Policy Brief #4 \u2013 Kenya [homepage on the Internet]. 2022. [cited 2024 Sept 25]. Available from: https:\/\/drive.google.com\/file\/d\/1iakIpnBgQ1vnLDTOw3NHloIvBp_Jyc3M\/view?usp=drive_link"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Gomez-Perez GP, De Graaff AE, Dekker JT, et al. Preparing healthcare facilities in sub-Saharan Africa for future outbreaks: Insights from a multi-country digital self-assessment of COVID-19 preparedness. BMC Health Serv Res. 2024;24(1):254. https:\/\/doi.org\/10.1186\/s12913-024-10761-2","DOI":"10.1186\/s12913-024-10761-2"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Rinke de Wit TF, Janssens W, Antwi M, et al. Digital health systems strengthening in Africa for rapid response to COVID-19. Front Health Serv. 2022;2:987828. https:\/\/doi.org\/10.3389\/frhs.2022.987828","DOI":"10.3389\/frhs.2022.987828"}],"container-title":["Journal of Public Health in Africa"],"original-title":[],"link":[{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/viewFile\/874\/html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/viewFile\/874\/epub","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/viewFile\/874\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/viewFile\/874\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/view\/874\/1689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:01:56Z","timestamp":1781683316000},"score":1,"resource":{"primary":{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/view\/874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/jphia.v16i1.874","relation":{},"ISSN":["2038-9922","2038-9930"],"issn-type":[{"value":"2038-9922","type":"print"},{"value":"2038-9930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"article-number":"a874"}}